SENS Stock: 2 Big Reasons Senseonics Is Squeezing Higher
SENS Stock: 2 Big Reasons Senseonics Is Squeezing Higher
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
InvestorPlace-股市新聞、股票諮詢和交易提示
Today, investors in Senseonics (NYSE:SENS) and SENS stock are seeing gains of approximately 12% at the time of writing. Indeed, today’s price action in this biotech play suggests investors are pricing in a relatively bullish outlook for this stock.
今天，投資者在感應學(紐約證券交易所股票代碼：SENS)和SENS股票在撰寫本文時的漲幅約為12%。事實上，這隻生物科技股今天的價格走勢表明，投資者對這隻股票的前景相對樂觀。
Such an outlook makes sense. After all, Senseonics’s core business model is focused on developing implantable continuous glucose-monitoring systems for those struggling with diabetes. Removing a key pain point (literally) for diabetes patients in having to prick their finger every few hours provides real value. Investors are betting that this technology will take off and the company will corner a rapidly growing market. Or, at least have a first-mover advantage.
這樣的觀點是有道理的。畢竟，Senseonics的核心業務模式是專注於為糖尿病患者開發植入式連續血糖監測系統。消除糖尿病患者每隔幾個小時就必須刺破手指的一個關鍵痛點(字面意思)是真正有價值的。投資者押注這項技術將會起飛，該公司將壟斷一個快速增長的市場。或者，至少擁有先發優勢。
Additionally, Senseonics has become a popular short-squeeze candidate among retail traders. Unsurprisingly, the company’s relatively high short interest ratio and low share price has something to do with this. Options traders are increasingly focusing on such plays as moonshot bets. As we’ve seen with previous meme-stock surges, anything’s possible.
此外，Senseonics已成為散户交易員中頗受歡迎的做空候選者。不出所料，該公司相對較高的短息率和較低的股價與此不無關係。期權交易員越來越關注像登月賭注這樣的遊戲。正如我們在之前的表情包庫存激增中看到的那樣，一切皆有可能。
That said, let’s look at a couple of catalysts driving SENS stock today.
話雖如此，讓我們來看看今天推動SENS股價上漲的幾個催化劑。
SENS Stock Higher on Key Catalysts
SENS股價在關鍵催化劑上走高
Today, retail investors are increasingly pointing out institutional interest in SENS stock. Indeed, it appears this biotech play has made its way to the big leagues. According to institutional buying data, BlackRock, among other investors, have loaded up on SENS stock. For retail investors, this is a big vote of confidence. Accordingly, social media is blowing up today covering these reports.
如今，散户投資者越來越多地指出機構對SENS股票的興趣。事實上，這場生物技術遊戲似乎已經進入了大聯盟。根據機構買入數據，貝萊德在其他投資者中，已經大量買入SENS股票。對於散户投資者來説，這是一張很大的信任票。因此，社交媒體今天對這些報道進行了鋪天蓋地的報道。
Additionally, investors appear to be pricing in some sort of announcement on the horizon for Senseonics’s Eversense monitor. The company announced its submission to the Food and Drug Administration (FDA) for this continuous glucose-monitoring system in October. Retail investors appear to be factoring in some sort of movement on this front.
此外，投資者似乎認為Senseonics的Everense顯示器即將發佈某種形式的聲明。該公司在10月份宣佈向食品和藥物管理局(FDA)提交了這一連續血糖監測系統。散户投資者似乎正在考慮這方面的某種動向。
Currently, SENS stock remains a highly volatile bet, best suited for aggressive investors. With no shortage of such investors in today’s market, this is a stock that could go on a run. However, as we’ve seen in the past, there’s significant downside risk with this stock. Investors should trade accordingly.
目前，SENS股票仍然是一個波動性很大的賭注，最適合激進的投資者。在今天的市場上，並不缺乏這樣的投資者，這是一隻可能會出現拋售的股票。然而，正如我們過去看到的那樣，這隻股票存在重大的下行風險。投資者應該進行相應的交易。
On the date of publication, Chris MacDonald did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
在本文發表之日，克里斯·麥克唐納(Chris MacDonald)沒有(直接或間接)持有本文提到的證券的任何頭寸。本文中表達的觀點是作者的觀點，受InvestorPlace.com發佈指南的約束。
The post SENS Stock: 2 Big Reasons Senseonics Is Squeezing Higher appeared first on InvestorPlace.
這篇帖子Senss Stock：Senseonics正在擠壓更高的兩大原因首先出現在InvestorPlace上。